$1.22
0.0453.85%
Last update: Nov 4, 9:29 AM

The average analyst price target for Purple Biotech is $1,108.50, 94643.6% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $17 to $2,200. The latest change came on Aug 7, 2026, when HC Wainwright & Co. lowered its price target on Purple Biotech from $30 to $17 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months